Science and Research

SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022

PURPOSE: The study evaluates the effects on sero-immunity, health status and quality of life of children and adolescents after the upsurge of the Omicron variant in Germany. METHODS: This multicenter cross-sectional study (IMMUNEBRIDGE Kids) was conducted within the German Network University Medicine (NUM) from July to October 2022. SARS-CoV-2- antibodies were measured and data on SARS-CoV-2 infections, vaccinations, health and socioeconomic factors as well as caregiver-reported evaluation on their children's health and psychological status were assessed. RESULTS: 497 children aged 2-17 years were included. Three groups were analyzed: 183 pre-schoolchildren aged 2-4 years, 176 schoolchildren aged 5-11 years and 138 adolescents aged 12-18 years. Positive antibodies against the S- or N-antigen of SARS-CoV-2 were detected in 86.5% of all participants (70.0% [128/183] of pre-schoolchildren, 94.3% of schoolchildren [166/176] and 98.6% of adolescents [136/138]). Among all children, 40.4% (201/497) were vaccinated against COVID-19 (pre-schoolchildren 4.4% [8/183], schoolchildren 44.3% [78/176] and adolescents 83.3% [115/138]). SARS-CoV-2 seroprevalence was lowest in pre-school. Health status and quality of life reported by the parents were very positive at the time of the survey (Summer 2022). CONCLUSION: Age-related differences on SARS-CoV-2 sero-immunity could mainly be explained by differences in vaccination rates based on the official German vaccination recommendations as well as differences in SARS-CoV-2 infection rates in the different age groups. Health status and quality of life of almost all children were very good independent of SARS-CoV-2 infection and/or vaccination. TRIAL REGISTRATION: German Registry for Clinical Trials Identifier Würzburg: DRKS00025546 (registration: 11.09.2021), Bochum: DRKS00022434 (registration:07.08.2020), Dresden: DRKS 00022455 (registration: 23.07.2020).

  • Engels, G.
  • Oechsle, A. L.
  • Schlegtendal, A.
  • Maier, C.
  • Holzwarth, S.
  • Streng, A.
  • Lange, B.
  • Karch, A.
  • Petersmann, A.
  • Streeck, H.
  • Blaschke-Steinbrecher, S.
  • Härtel, C.
  • Schroten, H.
  • von Kries, R.
  • Berner, R.
  • Liese, J.
  • Brinkmann, F.
  • Toepfner, N.

Keywords

  • Adolescent
  • Child
  • Humans
  • Child, Preschool
  • *Quality of Life
  • SARS-CoV-2
  • Cross-Sectional Studies
  • *COVID-19/epidemiology/prevention & control
  • Seroepidemiologic Studies
  • Antibodies, Viral
  • Vaccination
  • Children and adolescents
  • Omicron
  • Quality of life
  • Seroprevalence
Publication details
DOI: 10.1007/s15010-023-02052-5
Journal: Infection
Pages: 1531-1539 
Number: 5
Work Type: Original
Location: Assoziierter Partner, ARCN
Disease Area: PALI
Partner / Member: UKSH (Lübeck), UzL
Access-Number: 37280412

DZL Engagements

chevron-down